Results 301 to 310 of about 259,075 (330)

Treatment‐resistant depression

Australian Dental Journal, 2023
Manish Kumar Jha, Madhukar H. Trivedi
  +5 more sources

TREATMENT-RESISTANT BIPOLAR DEPRESSION

Psychiatric Clinics of North America, 1996
Patients with treatment-resistant bipolar depression require careful management, which takes into account the life-threatening potential of their depression and the risk of iatrogenic mania. Because there are few data specific to treatment of bipolar depression, much of the approach to bipolar depression is derived from experience with unipolar ...
openaire   +2 more sources

Vagus nerve stimulation: An update on a novel treatment for treatment-resistant depression.

Journal of Neurological Sciences, 2022
In this review, we provide an overview of essential clinical trials examining the effect of vagal nerve stimulation (VNS) in treatment-resistant depression (TRD), the applicable neuroanatomy of the vagus nerve, and the proposed mechanism of action (MOA ...
Lojine Y. Kamel, Willa Xiong, Britt M. Gott, Arun Kumar, C. Conway   +4 more
semanticscholar   +1 more source

Treatment-resistant depression

The Nurse Practitioner
ABSTRACT In 2023, the percentage of people in the US who experienced depression in their lifetime was at an all-time high of 29%. Depression causes considerable distress and functional impairment affecting quality of life, employment, and interpersonal relationships.
Leesa A. McBroom, Melissa Timmons
openaire   +2 more sources

A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 - January 2019.

Journal of Affective Disorders, 2020
BACKGROUND Sub-anaesthetic administration of ketamine is an emerging practice in patients presenting treatment resistant depression (TRD), however several outstanding questions have yet to be answered.
W. Marcantoni, Bertine Sandra Akoumba, M. Wassef, Julie Mayrand, H. Lai, S. Richard-Devantoy, S. Beauchamp   +6 more
semanticscholar   +1 more source

Treatment-resistant depression: molecular mechanisms and management

Molecular Biomedicine
Due to the heterogeneous nature of depression, the underlying etiological mechanisms greatly differ among individuals, and there are no known subtype-specific biomarkers to serve as precise targets for therapeutic efficacy. The extensive research efforts
Mayanja M. Kajumba, Angelina Kakooza-Mwesige, N. Nakasujja, Deborah C. Koltai, T. Canli   +4 more
semanticscholar   +1 more source

Insomnia and treatment-resistant depression

2023
Depression and sleep disturbance are related closely with bidirectional relationship. The heterogenic diagnostic criteria of major depressive disorder composed by the myriad combination of symptoms including sleep disturbance. Insomnia is an identifiable risk factor for depression and the treatment of insomnia might be able to prevent subsequent major ...
Wei-Chen, Lin, John Weyl, Winkelman
openaire   +2 more sources

Treatment-resistant depression.

The Journal of clinical psychiatry, 2006
Treatment-resistant depression (TRD) is a common clinical occurrence among patients treated for major depressive disorder. However, a clear consensus regarding the criteria defining TRD is lacking in the psychiatric community. Many patients who are considered treatment resistant are actually mis-diagnosed or inadequately treated.
Souery, Daniel, Papakostas, George I.George, Trivedi, Madhukar   +2 more
openaire   +1 more source

Tinnitus and treatment-resistant depression

2023
Tinnitus, a frequent disorder, is the conscious perception of a sound in the absence of a corresponding external acoustic sound source in the sense of a phantom sound. Although the majority of people who perceive a tinnitus sound can cope with it and are only minimaly impaired in their quality of lfe, 2-3% of the population perceive tinnitus as a major
Berthold, Langguth, An-Suey, Shiao, Jen-Tsung, Lai, Tai-Shih, Chi, Franziska, Weber, Martin, Schecklmann, Lieber Po-Hung, Li   +6 more
openaire   +2 more sources

Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression

Journal of Psychopharmacology, 2020
Background: Psilocybin has shown promise as a treatment for depression but its therapeutic mechanisms are not properly understood. In contrast to the presumed actions of antidepressants, we recently found increased amygdala responsiveness to fearful ...
L. Mertens, M. Wall, Leor Roseman, L. Demetriou, D. Nutt, R. Carhart-Harris   +5 more
semanticscholar   +1 more source